sapropterin dihydrochloride
Generic: sapropterin dihydrochloride
Labeler: endo usa, inc.Drug Facts
Product Profile
Brand Name
sapropterin dihydrochloride
Generic Name
sapropterin dihydrochloride
Labeler
endo usa, inc.
Dosage Form
POWDER, FOR SOLUTION
Routes
Active Ingredients
sapropterin dihydrochloride 500 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
49884-873
Product ID
49884-873_d7b2a60c-b7ac-4353-af15-8f0c5fafd172
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA210027
Listing Expiration
2026-12-31
Marketing Start
2020-10-01
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
49884873
Hyphenated Format
49884-873
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
sapropterin dihydrochloride (source: ndc)
Generic Name
sapropterin dihydrochloride (source: ndc)
Application Number
ANDA210027 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 500 mg/1
Packaging
- 30 PACKET in 1 CARTON (49884-873-72) / 1 POWDER, FOR SOLUTION in 1 PACKET (49884-873-52)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "d7b2a60c-b7ac-4353-af15-8f0c5fafd172", "openfda": {"upc": ["0349884873721"], "unii": ["RG277LF5B3"], "rxcui": ["1653217"], "spl_set_id": ["2e13a3b5-e4df-4d5c-9b26-02a7006a7c3e"], "manufacturer_name": ["ENDO USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 PACKET in 1 CARTON (49884-873-72) / 1 POWDER, FOR SOLUTION in 1 PACKET (49884-873-52)", "package_ndc": "49884-873-72", "marketing_start_date": "20201001"}], "brand_name": "SAPROPTERIN DIHYDROCHLORIDE", "product_id": "49884-873_d7b2a60c-b7ac-4353-af15-8f0c5fafd172", "dosage_form": "POWDER, FOR SOLUTION", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Phenylalanine Hydroxylase Activator [EPC]", "Phenylalanine Hydroxylase Activators [MoA]"], "product_ndc": "49884-873", "generic_name": "SAPROPTERIN DIHYDROCHLORIDE", "labeler_name": "ENDO USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "SAPROPTERIN DIHYDROCHLORIDE", "active_ingredients": [{"name": "SAPROPTERIN DIHYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA210027", "marketing_category": "ANDA", "marketing_start_date": "20201001", "listing_expiration_date": "20261231"}